KIMS QIP closes: 19.87m shares priced ₹755 (2026)

What KIMS announced

Krishna Institute of Medical Sciences (KIMS) said it has closed its Qualified Institutions Placement (QIP) on June 19, 2026. The company allotted 19,867,549 equity shares to eligible qualified institutional buyers (QIBs) at an issue price of ₹755 per share. The allotment price includes a premium of ₹753 per share on the face value of ₹2.

The QIP opened on June 16, 2026 and was carried out under Chapter VI of the SEBI ICDR Regulations. KIMS also referenced Sections 42 and 62(1)(c) of the Companies Act, 2013 for the issuance.

Pricing: discount to floor price

KIMS disclosed that the issue price of ₹755 reflected a discount of ₹16.73 per share, which is 2.17% of the floor price. The floor price for the QIP was ₹771.73 per share, computed under Regulation 176(1) of the SEBI ICDR Regulations.

Separately, a term sheet and placement document reviewed by Mint had indicated an indicative placement price of ₹755 per share and described it as a 3.04% discount to the day’s closing price of ₹778.65 on the National Stock Exchange. The same documents also described the price as a 2.17% discount to the floor price of ₹771.73.

Approvals and process followed

KIMS said its Finance and Investment Committee approved the closure of the issue period and finalised the allocation at a meeting held on June 19, 2026. The committee determined the issue price in consultation with the book running lead managers, applying the permitted discount to the floor price.

The company also stated that the allotment was finalised after it received application forms and funds in the escrow account from eligible buyers. It added that it has approved issuance of refund intimation letters to bidders who are entitled to refunds.

Placement document and disclosures

KIMS said the placement document dated June 19, 2026 has been filed with stock exchanges and is available on the company’s website. The company’s announcement also noted that the trading window for designated persons, which was closed since the QIP opening, will reopen 48 hours after determination of the issue price.

Use of proceeds: debt repayment and corporate purposes

Mint reported that KIMS launched the QIP to raise up to ₹1,500 crore (around $158 million) through a primary issuance of shares. The proceeds are planned to be used for repayment or prepayment of outstanding borrowings of the parent entity and its subsidiaries.

From the amount to be raised, ₹910 crore is meant for debt reduction at the listed entity. Another ₹215 crore is earmarked for debt clearance in subsidiaries Chalasani Hospitals Pvt., KIMS Hospitals Pvt., and KIMS Hospital Bengaluru Pvt. Ltd. The remaining amount is allocated to general corporate purposes, according to the same report.

Lead managers, lock-up and expected listing timeline

The book running lead managers named for the QIP were IIFL Capital and Jefferies India Pvt. Ltd, as per Mint’s report. The placement also includes a 60-day lock-up agreement for both the company and its promoting shareholders.

Mint had also reported that pricing for the deal was expected on or around Friday and that listing of the primary shares was likely on or around June 25.

Shareholding snapshot and operating footprint

Mint reported that promoters held a 34.11% stake in KIMS, while public shareholders, including mutual funds and non-institutional investors, made up the remaining 65.89%.

The company operates 26 multi-speciality and super-speciality hospitals under the KIMS Hospitals brand across Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala, with an aggregate bed capacity of 8,624 as of March 31.

Market context: QIPs in a cautious primary market

Mint described KIMS’ capital raise as coming during a subdued phase for India’s primary markets, citing volatility and weaker risk appetite amid geopolitical and macro uncertainty. The report also pointed to rupee pressure and sustained foreign investor outflows weighing on IPO activity.

It also referenced a separate Mint report dated June 10 which said India’s QIP pipeline was set for heavy activity, with listed firms lining up to raise over ₹30,000 crore.

Key numbers from the QIP

Stock performance snapshot shared in the report

The article also provided historical stock returns for Krishna Institute of Medical Sciences over multiple periods.

What investors will track next

Two immediate checkpoints follow the close of a QIP: the timeline for listing of the newly issued shares and clarity on the pace of debt prepayment. The company has already outlined that the trading window for designated persons will reopen 48 hours after the issue price determination.

KIMS had earlier secured board approval on March 11, 2026 and shareholder consent via postal ballot on April 15, 2026 for raising capital through this issuance. Subsequent disclosures around debt repayment at the parent and subsidiary level are likely to remain in focus as the company executes the stated use of proceeds.